Distinguish Pharmaceuticals LLC is categorized under Wholesale Pharmaceutical Products in Houston, TX and active since 2012.
Distinguish Pharmaceuticals LLC was established in 2012, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Toni Ingram at the company’s single location by writing to 12220 Beechnut St, Houston, Texas TX 77072 or by phoning (832) 206-3784. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Distinguish Pharmaceuticals LLC |
| Contact Person: | Toni Ingram |
| Address: | 12220 Beechnut St, Houston, Texas 77072 |
| Phone Number: | (832) 206-3784 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Distinguish Pharmaceuticals LLC was started in 2012 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Toni Ingram for inquiries that concern Distinguish Pharmaceuticals LLC by calling the company number (832) 206-3784, as your correspondence is most welcome. Additionally, the physical location of the single location of Distinguish Pharmaceuticals LLC can be found at the coordinates 29.689059,-95.592552 as well as the street address 12220 Beechnut St in Houston, Texas 77072.
For its online presence, you may visit Distinguish Pharmaceuticals LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.